In Countries More Biased Against Women, Higher COVID-19 Death Rates for Men Might Not Tell an Accurate Story
Many social factors put women at a higher risk of infection during a pandemic, since women usually assume the role ...
Why Try to Kill the Physician
New models of health try to standardize patient care. In the process, they simplify clinical decision-making. But there is a ...
The Art in the Science of Virtual Care
For virtual models of care to become sustainable, they must prioritize the patient experience - not only in the clinical ...
A Comment on Opioids for the CDC
The CDC released new guidelines for prescribing opioids, offering solace to many patients. But what is not included in the ...
The Risk of Concussion Lurks at the Super Bowl
Over the past two decades, researchers have gained a great deal of insight into the risks surrounding concussions – some ...
To Restore Patient Trust, Restructure Insurances
We have seen a rise in high deductible insurance policies, much to the chagrin of patients. Insurers should now acknowledge ...
Health Equity Does Not Mean What We Think
Health equity calls for equal patient outcomes. While laudable, it is not what most consider fair. If health equity means ...
Vaccine Hesitancy Proves Preventive Care Has Failed
We believe we can only treat a disease after it appears, like cause and effect, thinking which leads to vaccine ...
Healthcare Journalists are Suffering
The pandemic has pushed healthcare to the brink. Healthcare journalists struggle to make sense of it, finding themselves isolated, trapped ...
When Ease-of-use is the Endpoint
Healthcare struggles with thinking fast. We like snap decisions when treating diseases. But in the process, we have forgotten that ...
Care Gaps Predict Telemedicine Trends
We like to predict the future of telemedicine. But these predictions are often speculative. The most likely trends in telemedicine ...
Why Decision Makers Make Wrong Decisions
In recent weeks, the CDC has struggled with policy reversals and communication errors. Yet its leaders continue to project confidence ...
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more